Risk Factors and Mortality Associated with Default from Multidrug‐Resistant Tuberculosis Treatment | Zendy

Molly F. Franke | Zendy; Sasha C. Appleton | Zendy; Jaime Bayona | Zendy; Fernando Arteaga | Zendy; Eda Palacios | Zendy; Karim Llaro | Zendy; Sonya Shin | Zendy; Mercedes C. Becerra | Zendy; Megan Murray | Zendy; Carole D. Mitnick | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Risk Factors and Mortality Associated with Default from Multidrug‐Resistant Tuberculosis Treatment

Author(s) -

Molly F. Franke,

Sasha C. Appleton,

Jaime Bayona,

Fernando Arteaga,

Eda Palacios,

Karim Llaro,

Sonya Shin,

Mercedes C. Becerra,

Megan Murray,

Carole D. Mitnick

Publication year - 2008

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/588292

Subject(s) - medicine , hazard ratio , interquartile range , confidence interval , culture conversion , default , tuberculosis , sputum , pathology , finance , economics

Completing treatment for multidrug-resistant (MDR) tuberculosis (TB) may be more challenging than completing first-line TB therapy, especially in resource-poor settings. The objectives of this study were to (1) identify risk factors for default from MDR TB therapy (defined as prolonged treatment interruption), (2) quantify mortality among patients who default from treatment, and (3) identify risk factors for death after default from treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research